In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Vir Biotechnology Inc (NASDAQ: VIR) closed at $4.60 up 1.10% from its previous closing price of $4.55. In other words, the price has increased by $1.10 from its previous closing price. On the day, 1.31 million shares were traded.
Ratios:
For a deeper understanding of Vir Biotechnology Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.79 and its Current Ratio is at 6.79. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $23 previously.
On September 08, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $14.
JP Morgan Upgraded its Neutral to Overweight on March 06, 2023, whereas the target price for the stock was revised from $35 to $34.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 03 ’25 when De Backer Marianne sold 79,712 shares for $5.95 per share. The transaction valued at 474,239 led to the insider holds 769,505 shares of the business.
Marianne De Backer bought 79,712 shares of VIR for $474,239 on Apr 03 ’25. On Feb 26 ’25, another insider, de Verneuil Vanina, who serves as the EVP and General Counsel of the company, sold 7,373 shares for $9.14 each. As a result, the insider received 67,402 and left with 79,460 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 30.48 while its Price-to-Book (P/B) ratio in mrq is 0.61.
Stock Price History:
Over the past 52 weeks, VIR has reached a high of $14.45, while it has fallen to a 52-week low of $4.32. The 50-Day Moving Average of the stock is -24.53%, while the 200-Day Moving Average is calculated to be -41.69%.
Shares Statistics:
A total of 138.06M shares are outstanding, with a floating share count of 88.15M. Insiders hold about 36.23% of the company’s shares, while institutions hold 54.75% stake in the company.
Earnings Estimates
At present, 7.0 analysts are actively evaluating the performance of Vir Biotechnology Inc (VIR) in the stock market.The consensus estimate for the next quarter is -$0.8, with high estimates of -$0.58 and low estimates of -$1.07.
Analysts are recommending an EPS of between -$2.8 and -$4.07 for the fiscal current year, implying an average EPS of -$3.29. EPS for the following year is -$3.2, with 8.0 analysts recommending between -$2.45 and -$4.23.
Revenue Estimates
A total of 7 analysts have provided revenue estimates for VIR’s current fiscal year. The highest revenue estimate was $68M, while the lowest revenue estimate was $3M, resulting in an average revenue estimate of $17.2M. In the same quarter a year ago, actual revenue was $74.2MBased on 8 analysts’ estimates, the company’s revenue will be $25.55M in the next fiscal year. The high estimate is $90.6M and the low estimate is $3M.
